R&D base


28

2024-04

Continuously advancing internationalization | Keyuan Pharmaceutical establishes a dedicated task force to prepare for the FDA certification inspection!

Recently, Shandong Keyuan Pharmaceutical Co., Ltd. (stock code: 301281.SZ) established a dedicated task force to prepare for the certification inspection by the U.S. Food and Drug Administration (FDA). Led by President Wang Jianwei, the team includes key executives from relevant departments who have collectively developed a comprehensive and detailed action plan, ensuring that every aspect of the certification preparation is thoroughly and meticulously executed.

2024-04-28

19

2024-04

Facing the international stage, strategically positioning ourselves globally | Keyuan Pharmaceutical Makes a Stunning Debut at the 2024 World Pharmaceutical Ingredients (Japan) Exhibition!

Recently, the 2024 International Pharmaceutical Ingredients Exhibition kicked off with great fanfare in Tokyo, Japan. As one of the global benchmarks in the pharmaceutical industry, CPHI draws pharmaceutical companies, research institutions, and industry experts from around the world each year to jointly explore the latest trends and technological innovations shaping the pharmaceutical sector.

2024-04-19

03

2024-04

Promote action through learning, put learning into practice through action, and enhance efficiency through execution. | The Keyuan Lecture Series officially kicks off, injecting new momentum into high-quality development!

To promote the integration of learning and practice, and further enhance the comprehensive qualities and job skills of employees and cadres, Keyuan Grand Lecture Hall officially kicked off its first session on April 2nd, marking the official launch of the company’s new chapter in talent development and knowledge management—driven by "learning to boost action, putting action into practice, and leveraging action to improve efficiency!"

2024-04-03